Rise In Number Of Sports Injury Incidences Is Expected To Fuel The Growth Of Platelet-Rich Plasma Market By 10% CAGR During The Forecast Period

11 Aug 2022
www.biospace.com
Generic DrugImmunotherapyRadiation TherapyAcquisition
High Demand Of PRP In New Application Areas Such As Facelift Surgeries Is Expected To Elevate Its Prospects And Market Is Expected To Reach US $ 1.5 Billion By 2031 Fact.MR – A Market Research and Competitive Intelligence Provider: The global platelet-rich plasma market is anticipated to reach an impressive valuation of around US $ 1.5 Billion surpassing a CAGR of 12% during the forecast period (2021-2031). Platelet-rich plasma is rapidly used in healthcare institutes, especially for cosmetic surgeries and orthopedic surgeries. Moreover, various injuries such as tendon injuries, tennis elbow, and hamstring injury among others are treated quickly and effectively with the help of platelet-rich plasma therapy. The platelet-rich plasma market had surpassed a value of US $ 400 Million historically and had witnessed a CAGR of 10%. Moreover, rise in sports injuries in various developed economies such as UK have also pushed the demand further in coming years. Besides this, plasma is also commonly used for treatment of medical conditions such as facelift surgeries and erectile dysfunction. Moreover, rise in prevalence of androgenetic alopecia (AGA), i.e. hormone-related baldness in individuals across globe is acting as a key driver for the growth of the market. For more insights into the Market, Request Brochure of this Report Apart from this, platelet-rich plasma is widely used for tapping growth opportunities in hair and skin care. Also, micro needling, with the aid of platelet-rich plasma injections, offers unfolding opportunities to skin quality, skin-texture and appearance. Besides this, multiple advantages offered by plasma-rich platelet, including faster healing process, tissue repair and improvement in overall function have led to surge in demand. Apart from this, platelets play an important role in treating muscular injuries and healing wounds. Key Takeaways: United States is anticipated to dominate the platelet-rich plasma market during the forecast period. In addition to this, market is expected to witness a CAGR of 9% until 2031. U.K is projected to be the most profitable market for the plasma across Europe owing to rise in sports injuries. Moreover, market is projected to witness a CAGR of 8% through 2031. Countries such as India are anticipated to witness an impressive growth prospect of around 8% CAGR during the forecast period. Surge in consumption of platelet-rich plasma is anticipated due to high prevalence of inflammatory diseases. By End-User, Hospitals are expected to register a 10% CAGR during forecast period. Growth Drivers: Rise in number of patients opting for platelet-rich plasma injections is expected to boost the growth of the market. New application areas such as treatment for erectile dysfunction and facelift sure geris are expected to boost the growth of the market. Key players in the market are tapping growth opportunities in hair and skin care. Moreover, micro needling holds promising potential to improve skin texture and appearance. Also, key players in the market are significantly increasing their production of injections. Covid-19 pandemic has pushed the market growth further as high demand for plasma administration has elevated the prospects For Comprehensive Insights Ask An Analyst Here Competitive Landscape: The market is moderately competitive and the landscape comprises of key players that are active in the expansion of the global platelet rich-plasma market during the forecast period. Players are also putting emphasis on strategies to expand their product offerings and expand geographic presence. With advancement in technology, new players are entering the platelet-rich plasma market. In February 2021, Atlas Health Medical Group had announced availability of plasma-rich platelets to its patients. Moreover, in February 2020, EmCyte completed the acquisition of Cellmedix Holdings LLC that includes proprietary product system, namely Centrepid Platelet Concentrator. Key Companies Profiled by Fact.MR Arthrex, Inc. Johnson & Johnson Zimmer Biomet Holdings, Inc. Exactech, Inc. Stryker Corporation Terumo Medical Corporation Biotest Aktiengesellschaft CSL Ltd More Valuable Insights on Platelet-rich Plasma Market Segmentation of Platelet-rich plasma market Product Type Platelet-Rich Plasma Instruments Pure Platelet-Rich Plasma Kits Leucocyte-Rich Platelet-Rich Plasma Kits Platelet-Rich Fibrin Kits Pure Platelet-Rich Fibrin Kits Application Platelet-Rich Plasma for Orthopedic Surgery Platelet-Rich Plasma for Cosmetic Surgery Platelet-Rich Plasma for General Surgery Platelet-Rich Plasma for Neurosurgery Platelet-Rich Plasma for Other Surgeries End User Platelet-Rich Plasma Therapy in Hospitals Platelet-Rich Plasma Therapy in Orthopedic Clinics Platelet-Rich Plasma Therapy in Dermatology Clinics Platelet-Rich Plasma Therapy by Other End Users Get Customization on this Report for Specific Research Solutions Explore Fact.MR’s Coverage on the Healthcare Domain Basal Cell Carcinoma Treatment Market - Delay in basal cell carcinoma (BCC) treatment can lead to complications regarding the skin, muscle, and even bone damage. Hence, patients suffering from BCC are opting for non-surgical treatments such as superficial radiation therapy (SRT), since this treatment is associated with fewer complications. SRT is gaining increased popularity in the basal cell carcinoma treatment market. Cancer Immunotherapy Market - The cancer immunotherapy market garnered US$ 119.4 Bn by 2021, according to Fact.MR- a market research and intelligence provider. The market is expected to exceed US$ 310 Bn by registering a staggering CAGR of 10% by the end of the assessment period 2021-2031. Benign Prostatic Hyperplasia Treatment Market - Low-cost impact of generic drugs limits the sales opportunities for branded drugs, which creates concerns for leading players, as they invest huge capital to fuel their R&D activities. Though the sales of generic drugs fillip the growth of the BPH treatment market, their revenue contribution is significantly lesser as compared to branded drugs. Atherosclerosis Drugs Market - Nanotechnology is adding a new paradigm in the development of atherosclerosis drugs, owing to its selective drug delivery system that only targets damaged tissues. One such nano polymer, E-selectin-targeting polymer, is used for imaging and drug delivery applications to improve the function of heart muscles. Pulse Oximeters Market - The adoption of wireless pulse oximeters by clinicians and home users is increasing, which is expected to boost growth of the pulse oximeters market.The global pulse oximeters market is estimated at US$ 1.2 Bn in 2019, and projected to witness moderate growth during the forecast period (2019 - 2029). Arterial Stents Market - According to the latest analysis and report published by Fact.MR, the demand for arterial stents market is likely to grow at a steady pace between 2021 and 2031. Sensing the opportunities, key players are relying on innovations, sustainability, and product development to gain a major share in the market. Chemiluminescence Immunoassay (CLIA) Analyzers Market - The number of tests incorporating Chemiluminescence Immunoassay Analyzers (CLIA) techniques is forecast to aggrandize, attributed to technological advances in disease diagnosis, rise in demand for preventive diagnosis and treatment monitoring. Fluid Management Market - Revenues in the fluid management market are projected to grow at a robust rate between 2021 and 2031. Sensing the opportunities, key players are relying on innovations, sustainability, and product development to gain a major share in the market. Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market - Helicobacter Pylori infection, or H. Pylori, is the most prevalent bacterial infection, affecting the digestive tract and inner stomach lining. H. Pylori affects more than half of the world’s population. According to clinical findings, H. Pylori infection is the most prominent cause of dyspepsia, peptic ulcers and gastric adenocarcinoma. Animal Parasiticides Market - The increasing frequency of droughts, heat stress and flooding is increasing the spread of vector-borne diseases and macro-parasites, along with the emergence of new diseases and transmission models. Therefore, appropriate livestock management has become prevalent to prevent the loss of animals. About Fact.MR Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000's trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis. Contact: Mahendra Singh US Sales Office 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 E: sales@factmr.com Follow Us: LinkedIn | Twitter
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.